Nordwest Clinic (Krankenhaus)
Nordwest Clinic (Krankenhaus)
Germany, Frankfurt am Main
Elke Jaeger
41 years of experience
Clinic is certified :
Immunotherapy in Germany typically costs from $3,500 to $3,500. The final price depends on the specific drug protocol, cancer stage, and the number of treatment cycles required. Patients can expect significant savings compared to the US, where the average price is $30,000, representing a reduction of around 87%. Diagnosis usually includes PET/CT scans and multidisciplinary consultations at top-tier university clinics.
Bookimed Expert Insight: Germany offers unique value through research-driven clinics like Nordwest Clinic, which develops individual antitumor vaccines. While base rates are stable across Hamburg and Frankfurt, choosing academic centers like Charité Berlin provides access to AI-driven diagnostics. Patients often find the best value in Solingen, where University-affiliated experts provide top-tier care at approximately 20% lower administrative costs than private metropolitan hospitals.
Why choose Germany for immunotherapy?
Access advanced Immunotherapy solutions in trusted clinics .
| Germany | Turkey | Austria | |
| Immunotherapy | from $3,485 | from $2,200 | from $30,000 |
| Sarcoma Immunotherapy | from $90,000 | from $18,000 | from $60,000 |
| Immunotherapy for prostate cancer | from $50,000 | from $12,000 | from $30,000 |
| Immunotherapy for lung cancer | from $50,000 | from $18,000 | from $30,000 |
| Immunotherapy for breast cancer | from $22,000 | from $9,500 | from $35,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy journey.
Bookimed, a leading global medical tourism platform, is committed to helping clients looking for Immunotherapy in Germany by offering expert assistance and trustworthy medical solutions for every situation. Smart automatic ranking system is used to compose transparent clinic listings, meticulously maintained by a data scientist using AI for accuracy. The platform guarantees authenticity by publishing reviews from real patients after their treatments. Bookimed offers comprehensive medical solutions, with updates from clinics to ensure trustworthiness. The content about Immunotherapy in Germany, crafted by experienced medical authors and reviewed by specialists, adheres to Bookimed"s Editorial Guidelines, reflecting the platform"s commitment to delivering high-quality and clear health information. For more details or inquiries, feel free to contact us at marketing@bookimed.com or learn more about us and our mission here.
Professor Ralf Buhl is a leading neurosurgeon specializing in brain metastasis surgery and intracranial cavernomas treatment, actively contributing to scientific research.
Dr. Manuela Seifert leads the Breast Cancer Center at Solingen Clinic, specializing in breast-sparing surgeries and aesthetic reconstruction.
Chief Physician at BKZ Solingen's certified cancer center – Dr. Fox specializes in immunotherapy and molecular diagnostics for tumor diseases.
Prof. Elke Jaeger is one of Germany's top oncologists, recognized by Focus rating, with 41 years of experience of practice in oncology and hematology.
Written by Kateryna Zamkovska
Written by Kateryna Zamkovska
Written by Kateryna Zamkovska
When considering Immunotherapy, it’s important to understand the different techniques and which is best suited for you. Here’s a concise comparison of popular options:
Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.
Germany provides advanced immunotherapy options including checkpoint inhibitors, CAR T-cell therapy, and personalized cancer vaccines. Key clinics such as Nordwest and Charite Berlin utilize these treatments alongside dendritic cell therapy and oncolytic virus protocols to target specific tumors through highly individualized plans.
Bookimed Expert Insight: Focus on university-affiliated hospitals like Charite or Essen if seeking adoptive cell therapies. While private clinics offer standard inhibitors, these large research centers manage the highest patient volumes and lead clinical trials for newer experimental protocols not yet available in smaller facilities.
Patient Consensus: Patients often highlight that treatments are highly specialist-led, requiring specific referrals for access. Many emphasize the need to clarify whether you require oncology-based treatment or allergen immunotherapy before starting the process.
German oncologists actively treat Stage 4 cancers using advanced immunotherapy to trigger systemic immune responses. Centers like Medical Center in Solingen and Nordwest Clinic utilize checkpoint inhibitors and molecular diagnostics to target metastatic disease. Eligibility depends on specific biomarkers like PD-L1 expression or MSI-high status.
Bookimed Expert Insight: Success for late-stage cases often depends on molecular genetic screening rather than just cancer type. Clinics like Medical Center in Solingen integrate genetics into tumor board reviews. This allows doctors to identify specific mutations that make Stage 4 tumors vulnerable to immunotherapy even when standard treatments fail.
Patient Consensus: Patients report that while Stage 4 immunotherapy provides hope, eligibility hinges entirely on biomarker results. Many emphasize the importance of thorough molecular testing at major university hospitals to confirm if their specific tumor will respond.
Immunotherapy success in Germany follows global oncology standards, typically achieving clinical benefit in 20% to 50% of advanced-stage patients. Specific response rates depend on cancer type and biomarkers, with university hospitals providing access to advanced drug therapies and molecular diagnostics certified by the German Cancer Society.
Bookimed Expert Insight: While base response rates for solid tumors often hover around 25%, German university hospitals utilize clinical trials to improve outcomes. Our data shows that top centers like Nordwest Clinic integrate research and patient care. This allows patients to access next-generation therapies before they become global standards.
Patient Consensus: Patients value the clarity and precision of German oncologists. They frequently highlight the detailed consultations where doctors explain exactly how immunotherapy targets their specific tumor type.